Brief: FDA Accepts Tiziana Life Sciences Fast Track Designation Submission For Treatment Of Multiple Sclerosis
11/06/2024 13:17
June 11 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* FDA ACCEPTS TIZIANA LIFE SCIENCES FAST TRACK DESIGNATION
SUBMISSION FOR TREATMENT OF MULTIPLE SCLEROSIS
Source text for Eikon: ID:nGNX44sswP
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study